Bank of Montreal
AXSM icon

Bank of Montreal’s Axsome Therapeutics AXSM Stock Holding History

Bank of Montreal’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,531
Closed -$849K – 3857
2024
Q2 		$849K Buy
+10,531
New +$780K ﹤0.01% 2117
2021
Q2 		– Sell
-786
Closed -$43K – 3747
2021
Q1 		$43K Sell
786
-3,507
-82% -$247K ﹤0.01% 3769
2020
Q4 		$335K Buy
4,293
+3,009
+234% +$225K ﹤0.01% 2929
2020
Q3 		$94K Sell
1,284
-918
-42% -$71.5K ﹤0.01% 3110
2020
Q2 		$180K Buy
+2,202
New +$169K ﹤0.01% 2784
2020
Q1 		– Sell
-3,180
Closed -$329K – 4104
2019
Q4 		$329K Buy
3,180
+973
+44% +$39.3K ﹤0.01% 2892
2019
Q3 		$45K Buy
2,207
+174
+9% +$4.47K ﹤0.01% 3667
2019
Q2 		$52K Buy
+2,033
New +$40.7K ﹤0.01% 3664

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's AXSM Position: Q3 2024 in Review

Bank of Montreal sold out of Axsome Therapeutics (AXSM) in Q3 2024, closing a stake of 10,531 shares — an estimated $849K sold.

Bank of Montreal first reported a position in AXSM in Q2 2019 and held it in 8 quarters. The position peaked at $849K in Q2 2024. 279 funds tracked by Wall St. Rank hold AXSM as of Q3 2024.

  • Bank of Montreal reported no remaining Axsome Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 10,531 Axsome Therapeutics shares in Q3 2024, an estimated $849K.
  • Bank of Montreal first reported a position in Axsome Therapeutics in Q2 2019 and held it in 8 quarters.
  • Bank of Montreal's Axsome Therapeutics position peaked at $849K in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.